Trial Profile
Study of [18F]-AV-1451 binding profile in early and late-onset alzheimer's disease and suspected non-alzheimer pathophysiology
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 12 Oct 2018 New trial record